P210 Defining the minimal important difference for the visual analogue scale for dyspnoea in patients with malignant pleural effusions

P210 Defining the minimal important difference for the visual analogue scale for dyspnoea in patients with malignant pleural effusions

Bibliographic Details
Main Authors:	Mishra, E, Corcoran, J, Hallifax, R, Stradling, J, Maskell, N, Rahman, N
Format:	Journal article
Published:	BMJ Publishing Group 2013

Similar Items

Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
by: Mishra, E, et al.
Published: (2015)

Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
by: Eleanor K Mishra, et al.
Published: (2015-01-01)

THE USE OF INDWELLING PLEURAL CATHETERS FOR THE MANAGEMENT OF NON-MALIGNANT RECURRENT PLEURAL EFFUSIONS
by: Bhatnagar, R, et al.
Published: (2012)

Modern management of malignant pleural effusions
by: Mercer, R, et al.
Published: (2016)

Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set
by: Mercer, RM, et al.
Published: (2019)

An unusual cause of progressive dyspnoea, pulmonary nodules and pleural effusions
by: Sudharsan Venkatesan, et al.
Published: (2024-01-01)

Biological markers of successful pleurodesis for malignant pleural effusion
by: Psallidas, I, et al.
Published: (2016)

Thoracic ultrasonography as a predictor of pleurodesis success in malignant pleural effusion
by: Corcoran, J, et al.
Published: (2017)

Thoracic ultrasound as an early predictor of pleurodesis success in malignant pleural effusion
by: Corcoran, J, et al.
Published: (2018)

Retrospective analysis of survival time in malignant pleural effusion requiring IPC insertion
by: Asciak, R, et al.
Published: (2017)

Biological markers of favourable prognosis and successful pleurodesis for malignant pleural effusion
by: Psallidas, I, et al.
Published: (2016)

Assessment and treatment of malignant pleural effusions: visual analogue scale, ultrasound and drainage
by: Mishra, EK
Published: (2013)

Malignant pleural effusion management: keeping the flood gates shut
by: Walker, S, et al.
Published: (2019)

Survival and pleurodesis outcome in patients with malignant pleural effusion – post-hoc analysis from the TIME-1 trial
by: Hassan, M, et al.
Published: (2018)

Indwelling pleural catheters for non-malignant effusions: a multicentre review of practice.
by: Bhatnagar, R, et al.
Published: (2014)

The palliation of malignant pleural effusions.
by: Bhatnagar, R, et al.
Published: (2012)

Management of malignant pleural effusion
by: McCracken, D, et al.
Published: (2018)

ERS/EACTS statement on the management of malignant pleural effusions
by: Bibby, A, et al.
Published: (2018)

Breathlessness post-drainage predicts survival in patients with malignant pleural effusion
by: Mishra, E, et al.
Published: (2018)

Randomised controlled trial of urokinase versus placebo for non-draining malignant pleural effusion
by: Mishra, E, et al.
Published: (2018)

Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
by: Psallidas, I, et al.
Published: (2018)

Ultrasound in predicting improvement in dyspnoea after therapeutic thoracentesis in patients with recurrent unilateral pleural effusion
by: Katrine Fjaellegaard, et al.
Published: (2024-12-01)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
by: Ellayeh, M, et al.
Published: (2021)

P234 Patient and fluid characteristics associated with non-draining malignant pleural effusion
by: Mishra, E, et al.
Published: (2017)

Objective thoracoscopic criteria in differentiation between benign and malignant pleural effusions
by: Ellayeh, M, et al.
Published: (2021)

Investigating suspected malignant pleural effusion.
by: Rahman, N, et al.
Published: (2007)

Survival in patients with malignant pleural effusion undergoing talc pleurodesis
by: Hassan, M, et al.
Published: (2019)

Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.
by: Olfert, J, et al.
Published: (2016)

Malignant pleural mesothelioma with resolution of pleural effusion
by: Sayaka Nishida, et al.
Published: (2023-11-01)

Derrame pleural neoplásico Malignant pleural effusion
by: Lisete Ribeiro Teixeira, et al.
Published: (2006-08-01)

ERS/EACTS statement on the management of malignant pleural effusions
by: Bibby, AC, et al.
Published: (2018)

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion
by: Ellayeh, MA, et al.
Published: (2021)

Biomarkers of malignancy in pleural effusions
by: José M. Porcel, et al.
Published: (2024-10-01)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion.
by: Morel, A, et al.
Published: (2011)

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion
by: Morel, A, et al.
Published: (2011)

Thoracic ultrasound in the diagnosis of malignant pleural effusion.
by: Qureshi, N, et al.
Published: (2009)

Chemotherapy does not increase the risk of pleural infection in patients managed with an indwelling pleural catheter for malignant pleural effusion
by: Morel, A, et al.
Published: (2010)

Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
by: Maskell, N, et al.
Published: (2003)

Malignant melanoma presenting as an isolated pleural effusion
by: M. Shameem, et al.
Published: (2015-12-01)

Malignant pleural effusion: From diagnostics to therapeutics.
by: Asciak, R, et al.
Published: (2017)